Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Viva Gold Reports Multiple High-Grade Gold Hits at the Tonopah Gold Project (click to learn more) Xcyte Digital Corp. Signs Agreement to Purchase Assets of Webinar.net (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Akorn AKRXQ

Healthcare Drug Manufacturers - Major
Akorn Inc is a pharmaceutical company. It is engaged in the development, manufacturing, and marketing of generic and prescription pharmaceuticals. The firm has two segments namely Prescription Pharmaceuticals and Consumer Health. The Prescription Pharmaceuticals segment consists of generic and branded prescription pharmaceuticals including sterile ophthalmics, injectables, and inhalants, and... see more

Recent & Breaking News (OTCPK:AKRXQ)

Akorn Comments on Delaware Chancery Court Ruling

Business Wire October 1, 2018

Factors of Influence in 2018, Key Indicators and Opportunity within Five Prime Therapeutics, Akorn, The Blackstone Group, Avaya, Tractor Supply, and CymaBay Therapeutics — New Research Emphasizes Economic Growth

GlobeNewswire August 1, 2018

Lawsuit for Investors in shares of Akorn, Inc. (NASDAQ: AKRX) announced by Shareholders Foundation

GlobeNewswire June 4, 2018

Moore Kuehn, PLLC Announces an Investigation Involving Possible Breaches of Fiduciary Duties by Officers and Directors of Akorn, Inc.

PR Newswire May 29, 2018

Benzinga's Daily Biotech Pulse: Portola Receives FDA Nod, Mallinckrodt Gets Thumbs Down

Benzinga.com  May 4, 2018

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Henry Schein, Inc. of Class Action Lawsuit and Upcoming Deadline – HSIC

Business Wire May 2, 2018

FINAL DEADLINE ALERT: Brower Piven Reminds Shareholders Of Approaching Deadline In Class Action Lawsuit And Encourages Those Who Have Losses In Excess Of $100,000 From Investment In Akorn, Inc. (Nasdaq: AKRX) To Contact The Firm

GlobeNewswire May 2, 2018

Rosen Law Firm Reminds Akorn, Inc. Investors of Important May 7 Deadline in Class Action – AKRX

GlobeNewswire May 1, 2018

SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Gridsum Holding Inc. (GSUM) & Lead Plaintiff Deadline - June 25, 2018

PR Newswire April 30, 2018

Lifshitz & Miller LLP Announces Investigation of Acadia Healthcare Company, Inc., Akorn, Inc., Blackhawk Network Holdings, Inc., Facebook, Inc., IZEA Inc., MuleSoft, Inc., Solid Biosciences Inc., and Tableau Software, Inc.

PR Newswire April 24, 2018

35 Biggest Movers From Yesterday

Benzinga.com  April 24, 2018

AKORN INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 In Akorn, Inc.To Contact The Firm

Business Wire April 23, 2018

28 Stocks Moving In Monday's Mid-Day Session

Benzinga.com  April 23, 2018

Mid-Morning Market Update: Markets Mostly Flat; Hasbro Misses Q1 Expectations

Benzinga.com  April 23, 2018

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Akorn, Inc. of Class Action Lawsuit and Upcoming Deadline – AKRX

Business Wire April 23, 2018

Should you buy or sell Akorn Inc., Google, Halliburton, Hasbro and Verizon Communications?

PR Newswire April 23, 2018

Akorn Asks Delaware Court to Require Fresenius Kabi to Fulfill Its Obligations under Merger Agreement

Business Wire April 23, 2018

Akorn Issues Statement

Business Wire April 22, 2018

AKRX INVESTOR ALERT: Rosen Law Firm Reminds Akorn, Inc. Investors of Important May 7 Deadline in Class Action – AKRX

Business Wire April 21, 2018

Analysis: Positioning to Benefit within Team, Fortinet, Rockwell Collins, Franklin Street Properties, Akorn, and Targa Resources — Research Highlights Growth, Revenue, and Consolidated Results

GlobeNewswire April 20, 2018